MedTech News
.................... by Andrew Celentano
Handheld TB test delivers lab-level accuracy in under 30 minutes
In a study published in the New England Journal of Medicine, researchers at UC San Francisco and UC Irvine show the device is as effective as a laboratory test and can detect cases even among people who have trouble producing phlegm samples from deep within their lungs.
Experiments advance efforts to restore vision with transplanted neurons
Researchers at Johns Hopkins Medicine say they have successfully demonstrated that disrupting an eye structure long suspected of blocking the growth and survival of transplanted nerve cells may help restore vision in people with optic nerve damage.
AI model could warn of cardiac arrest 10 to 15 minutes early
Researchers developed the Cardiac Autoregressive Model for ECG Language-Modeling (CAMEL), an artificial intelligence model that treats ECG less like isolated snapshots and more like language.
Tumor-on-a-chip reveals how pancreatic cancer interacts with scar tissue and resists treatment
Researchers developed a “tumor-on-a-chip” system designed to recreate that environment outside the human body, offering a more realistic way to study the disease and evaluate treatments.
AI computation enables clearer views of the deep brain, bypassing the need for expensive equipment
Professor Iksung Kang (School of Electrical Engineering), in collaboration with Professor Na Ji’s research team at UC Berkeley, has developed a technology that accurately corrects image aberrations in microscopes used for live biological imaging.
PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® – Early-Stage Invasive Breast Cancer Assay
LAGUNA HILLS, Calif., April 29, 2026 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the AidaBREAST® test.
Chest Wall Innovations Receives FDA 510(k) Clearance for PC Fix Rib Fixation System
HERSHEY, Pa., April 29, 2026 /PRNewswire/ — Chest Wall Innovations, a medical device company focused on advancing the standard of care in chest wall surgery, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its PC Fix Rib Fixation System on April 24, 2026, clearing the path for U.S. commercialization.
Harnessing the Power of AI to Fight Lyme Disease
An anonymous gift helped Tufts researchers speed up a project to develop new drugs that could prevent and treat Lyme disease